Comparison of the results of percutaneous transluminal angioplasty and stenting with medical treatment for claudicants who have superficial femoral artery occlusive disease

Vascular

Volumn 14, Issue 2, 2006, Pages 81-87

  Wilson, Samuel ^a,b   Gelfand, Dmitri ^a   Jimenez, Juan ^a   Gordon, Ian ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA LONG BEACH HEALTHCARE SYSTEM   (United States)

Author keywords

Angioplasty; Arterial occlusion; Claudication

Indexed keywords

ACETYLSALICYLIC ACID;

ANAMNESIS; ANKLE BRACHIAL INDEX; ARTERY OCCLUSION; CLINICAL STUDY; CLINICAL TRIAL; CONSERVATIVE TREATMENT; DOSE RESPONSE; EXERCISE; HUMAN; INTERMETHOD COMPARISON; KNEE AMPUTATION; LEG REVASCULARIZATION; LONG TERM CARE; MEDICAL EDUCATION; MEDICAL LITERATURE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SMOKING CESSATION; STENT; SUPERFICIAL FEMORAL ARTERY; TREATMENT OUTCOME; VASCULAR PATENCY; WALKING;

ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; EXERCISE THERAPY; FEMORAL ARTERY; HUMANS; INTERMITTENT CLAUDICATION; STENTS; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 33745915272     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.2310/6670.2006.00017     Document Type: Review

References (39)

1. Meijer WT, Hoes AW, Rutgers D, et al. Peripheral arterial disease in the elderly: the Rotterdam study. Arterioscler Thromb Vasc Biol 1998;18:185-92.
2. Collins TC, Petersen NJ, Suarez-Almazor M, et al. The prevalence of peripheral arterial disease in a racially diverse population. Arch Intern Med 2003;163:1469-74.
3. Diehm C, Schuster A, Allenberg JR, et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross sectional study. Atherosclerosis 2004;172: 95-105.
4. Aquino R, Johnnides C, Makaroun M, et al. Natural history of claudication: long-term serial follow-up study of 1244 claudicants. J Vasc Surg 2001;34:962-70.
5. National Library of Medicine digital archive. Available at: www. pubmed.org (accessed Dec 2005).
6. Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA 1995;274:975-80.
7. Gartenmann CH, Kirchberger I, Herzig M, et al. Effects of exercise training program on functional capacity and quality of life in patients with peripheral arterial occlusive disease. Evaluation of a pilot project. Vasa 2002;31:29-34.
8. Tsai JC, Chan P, Wang CH, et al. The effects of exercise training on walking function and perception of health status in elderly patients with peripheral arterial occlusive disease. J Intern Med 2002;252:448-55.
9. Gardner AW, Killewish LA, Montgomery PS, et al. Response to exercise rehabilitation in smoking and nonsmoking patients with intermittent claudication. J Vasc Surg 2004;39:531-7.
10. Duda SH, Pusich B, Richter G, et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation 2002;106:1505-9.
11. Murray JG, Apthorp LA, Wilkins RA. Long-segment (> 10 cm) femoropopliteal angioplasty: improved technical success and long-term patency. Radiology 1995;195:158-62.
12. Soder HK, Manninen HI, Rasanen HT, et al. Failure of prolonged dilation to improve long-term patency of femoropopliteal artery angioplasty: results of a prospective trial. J Vasc Interv Radiol 2002;13:361-9.
13. Jamsen TS, Manninen HI, Jaakkola PA, Matsi PJ. Long-term outcome of patients with claudication after balloon angioplasty of the femoropopliteal arteries. Radiology 2002;225:345-52.
14. Henry M, Amor M, Ethevenot G, et al. Palmaz stent placement in iliac and femoropopliteal arteries: primary and secondary patency in 310 patients with 2-4 year follow-up. Radiology 1995;197:167-74.
15. White GH, Liew SC, Waugh RC, et al. Early outcome and intermediate follow-up of vascular stents in the femoral and popliteal arteries without long-term anticoagulation. J Vasc Surg 1995;21:270-9.
16. Strecker EP, Boos IB, Gottmann D. Femoropopliteal artery stent placement: evaluation of long-term success. Radiology 1997;205:375-83.
17. Cejna M, Thurnher S, Illiasch H, et al. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Radiol 2001;12:23-31.
18. Gordon IL, Conroy RM, Arefi M, et al. Three-year outcome of endovascular treatment of superficial femoral artery occlusion. Arch Surg 2001;136:221-8.
19. Costanza MJ, Queral LA, Lilly MP, Finn WR. Hemodynamic outcome of endovascular therapy for TransAtlantic InterSociety Consensus type B femoropopliteal arterial occlusive lesions. J Vasc Surg 2004;39:343-50.
20. Creasy TS, McMillan PJ, Fletcher EWL, et al. Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomized trial. Eur J Vasc Endovasc Surg 1990;4:135-40.
21. Perkins JM, Collin J, Creasy TS, et al. Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective randomized trial. Eur J Vasc Endovasc Surg 1996;11:409-13.
22. Whyman MR, Fowkes FGR, Kerracher EMG, et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. J Vasc Surg 1997;26:551-7.
23. TransAtlantic Inter-Society Consensus (TASC). Management of peripheral arterial disease (PAD), section B: intermittent claudication. Eur J Vasc Endovasc Surg 2000;19 Suppl A:S47-114.
24. Saxon RR, Coffman JM, Gooding JM, et al. Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial. J Vasc Interv Radiol 2003;14:303-11.
25. Henry M, Amor M, Beyar R, et al. Clinical experience with a new nitinol self-expanding stent in the peripheral arteries. J Endovasc Surg 1996;3:369-79.
26. Dormandy JA, Murray GD. The fate of the claudicant - a prospective study of 1969 claudications. Eur J Vasc Surg 1991;5:131-3.
27. Muluk SC, Muluk VS, Kelley ME, et al. Outcome events in patients with claudication: a 15-year study in 2777 patients. J Vasc Surg 2001;33:251-8.
28. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992;326:381-6.
29. Bowlin SJ, Medalie JH, Flocke SA, et al. Intermittent claudication in 8343 men and 21-year specific mortality follow up. Ann Epidemiol 1997;7:180-7.
30. Matsagas MI, Geroulakos G, Mikhailidis DP, et al. The role of platelets in peripheral arterial disease: therapeutic implications. Ann Vasc Surg 2002;16:246-58.
31. Falk E, Fernandez-Ortiz A. The role of thrombosis in atherosclerosis and its complications. Am J Cardiol 1995;75:3B-11B.
32. Reininger C, Graf J, Reininger A, et al. Increased platelet and coagulatory activity indicate ongoing thrombogenesis in peripheral arterial disease. Thromb Res 1996;82:523-32.
33. Beebe HG, Dawson DL, Cutler BS, et al. A new pharmacological treatment for intermittent claudication: results of a randomized multicenter trial. Arch Intern Med 1999;159:2041-50.
34. Okuda Y, Kimura Y, Yamashita K. Cilostazol. Cardiovasc Drug Rev 1993;11:451-65.
35. Dawson DL, Cutler BS, Meissner MH, et al. Cilostazol has beneficial effects in the treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial. Circulation 1998;98:678-86.
36. Thompson PD, Zimet R, Forbes WP, et al. Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication. Am J Cardiol 2002;90:1314-9.
37. Money SR, Herd JA, Isaacsohn JL, et al. Effect on cilostazol on walking distances in patients with intermittent claudication caused by peripheral disease. J Vasc Surg 1998;27:267-74.
38. TransAtlantic InterSociety Consensus (TASC) Working Group. Management of peripheral arterial occlusive disease: TASC document. J Vasc Surg 2000;31(1 Pt 2):S1-296.
39. Sapoval MR, Long AL, Raynaud AC, et al. Femoropopliteal stent placement: long-term results. Radiology 1992;184:833-9.